http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1681296-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8daee6fadbc9271431db49d888ef703e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7028
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H1-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-53
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7028
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H1-08
filingDate 2004-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b12eb273608fd3b778bd9f6ac028c92
publicationDate 2006-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1681296-A1
titleOfInvention Epimeredi glycoside a, the formulation containing thereof and their preparation method
abstract The invention relates to Epimeredinoside A and its structure as shown in Fig. I, and the preparation methods of pharmaceutics made from the Epimeredi indica root extract containing Epimeredinoside A. It includes all kinds of oral pharmaceutics made up of the Epimeredi indica root extract and pharmaceutical adjuvants. The root extract is the extracta sicca prepared by extracting water and concentrating the Epimeredi indica root to contain 0.10 % to 1.50 % of Epimeredinoside A. The invention, pharmaceutical preparations of Epimeredi indica root extract, DOES NOT contain any hormones. NO progesterone has to be taken in to prevent the side effects of using this drug. The pharmaceutical preparation has doubtless clinical effects and is stable, controllable and safe, thereby being especially compatible for the female menopause.
priorityDate 2003-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426208998
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410541
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14055602
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6342
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413227
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54691413
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID516069
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405992
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413228
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID516069
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393829
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419477469
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5994
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393830
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419584780
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399016
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460029
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134688829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6713579
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546111
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID709
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136160036
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128426949
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433323226
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45051774
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445858
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19233
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553937
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559502

Total number of triples: 64.